Christopher Ritchlin, MD
Enriched profileProfessor of Medicine (Part-Time), Chief, Division of Allergy, Immunology and Rheumatology · University of Rochester Medical Center
Christopher Ritchlin is Professor of Medicine (Part-Time), Chief, Division of Allergy, Immunology and Rheumatology at University of Rochester Medical Center. OpenAlex indexes 490 publications with 22,230 citations (h-index 67); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 1 Sept 2026
Christopher Ritchlin, MD, is Professor of Medicine (Part-Time), Chief, Division of Allergy, Immunology and Rheumatology at University of Rochester Medical Center. The public record shows 490 publications with 22,230 citations (h-index 67), centered on Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 17 companies, 3 NIH-funded awards (2001–2026).
- Most recent indexed publication: 2026 · Advances in therapy
- Top research focus: Spondyloarthritis Studies and Treatments
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 53 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 205.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Sept 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)
Sponsor: University of Rochester
- Teriparatide as a Chondroregenerative Therapy in OA
Sponsor: Christopher Ritchlin
Industry payments
Updated 1 Sept 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year202543 payments$17,601openpaymentsdata.cms.gov ↗
- UCB SAProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year202539 payments
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%JAK inhibitor100%Rinvoq100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 1 Sept 2026
3 NIH research awards on record, funded 2001–2026 per NIH RePORTER. The latest:
- ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
University of Rochester
FY2026$4,048,118UC2AR081029 - ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
University of Rochester
FY2025$600,000UC2AR081029 - ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
University of Rochester
FY2024$600,000UC2AR081029
Publications
Updated 1 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis.
Advances in therapy
Review2026 - Synovial Telocytes are Characterized by Efhd1, Dpp4, and Pi16 Expression, Show High Responsiveness to Osmotic Stress, and Exhibit Fibroblast Plasticity Potential.
Arthritis & rheumatology (Hoboken, N.J.)
Article2026 - Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.
Rheumatology (Oxford, England)
Clinical Trial2026 - Telocyte Deletion Associated With Loss of Lymphatic Drainage and Exacerbation of Inflammatory-Erosive Arthritis in Mice.
Arthritis & rheumatology (Hoboken, N.J.)
Article2026
Most-cited works
by citation count (OpenAlex)- 01Psoriatic ArthritisArticle1,376 citations2017
- 02
- 03
- 04
- 05
Network
Updated 1 Sept 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 1 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/christopher-ritchlin-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/christopher-ritchlin-3a8869295
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Christopher-Ritchlin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
podtail.com/podcast/psound-bytes/ep-30-insights-on-the-prevention-of-psoriatic-arth
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podtail.com ↗ - Other
healio.com/news/rheumatology/20160601/video-ritchlin-discusses-new-markers-used-for-treatment-of-psoriasis-psoriatic-arthritis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗ - Other
medscape.com/viewarticle/959148
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 1 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- Board Certified
Internal Medicine (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗ - Board Certified
Rheumatology (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urmc.rochester.edu ↗
- Member
Scientific Advisory Committee, National Psoriasis Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urmc.rochester.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
Clinical Immunology Research Unit, University of Rochester Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗ - Co-founder/Co-Director
URMC Psoriasis Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podtail.com ↗ - Principal site investigator
International Psoriatic Arthritis Research Team (IPART) database (one of six sites)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urmc.rochester.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
- Psound Bytes podcast (National Psoriasis Foundation)
Ep. 30: "Insights on the Prevention of Psoriatic Arthritis"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podtail.com ↗ - Video interview
Rheumatology Live: "Safety and Efficacy of Bimekizumab for Psoriatic Arthritis"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheum-live.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Louis Constine, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Edward Messing, MD
University of Rochester Medical Center